Jüri Teras, Hidde M Kroon, John T Miura, Tim Kenyon-Smith, Georgia M Beasley, Dean Mullen, Norma E Farrow, Paul J Mosca, Michael C Lowe, Clara R Farley, Aishwarya Potdar, Hala Daou, James Sun, Michael Carr, Jeffrey M Farma, Michael A Henderson, David Speakman, Jonathan Serpell, Keith A Delman, B Mark Smithers, Andrew Barbour, Douglas S Tyler, Brendon J Coventry, Jonathan S Zager, John F Thompson
BACKGROUND: Isolated limb infusion (ILI) is used to treat in-transit melanoma metastases confined to an extremity. However, little is known about its safety and efficacy in octogenarians and nonagenarians (ON). PATIENTS AND METHODS: ON patients (≥ 80 years) who underwent a first ILI for American Joint Committee on Cancer seventh edition stage IIIB/IIIC melanoma between 1992 and 2018 at nine international centers were included and compared with younger patients (< 80 years)...
March 9, 2020: Annals of Surgical Oncology